Literature DB >> 11343414

Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies.

M Zhang1, D Methot, V Poppa, Y Fujio, K Walsh, C E Murry.   

Abstract

M. Zhang, D. Methot, V. Poppa, Y. Fujio, K. Walsh and C. E. Murry. Cardiomyocyte Grafting for Cardiac Repair: Graft Cell Death and Anti-Death Strategies. Journal of Molecular and Cellular Cardiology (2001) 33, 907-921. Recent studies indicate that cardiomyocyte grafting forms new myocardium in injured hearts. It is unknown, however, whether physiologically significant amounts of new myocardium can be generated. Pilot experiments showed that death of grafted rat neonatal cardiomyocytes limited formation of new myocardium after acute cryoinjury. Time-course studies showed that, at 30 min after grafting, only 1.8(+/-0.4)% of graft cells were TUNEL-positive. At 1 day, however, TUNEL indices increased to 32.1(+/-3.5)% and remained high at 4 days, averaging 9.8(+/-3.8)%. By 7 days, TUNEL decreased to 1.0(+/-0.2)%. Electron microscopy revealed that dead cells had features of both irreversible ischemic injury and apoptosis. To test whether ischemia contributed to poor graft survival, grafts were placed into vascularized 2-week-old cardiac granulation tissue or normal myocardium. TUNEL indices were reduced by 53% and 86%, respectively. Adenoviral infection of graft cells with the cytoprotective kinase Akt, or constitutively active Akt, reduced TUNEL indices by 31% and 40%, respectively, compared to beta -gal-transfected controls. Neither treatment reached statistical significance compared to untreated controls, however. Heat shock reduced cardiomyocyte death in vitro in response to serum deprivation, glucose depletion, and viral activation of the Fas death pathway. When cardiomyocytes were heat shocked prior to grafting, graft cell death in vivo was reduced by 54% at day 1. Therefore, high levels of cardiomyocyte death occur for at least 4 days after grafting into injured hearts, in large part due to ischemia. Death can be limited by activating the Akt pathway and even more effectively by heat shock prior to transplantation. Copyright 2001 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343414     DOI: 10.1006/jmcc.2001.1367

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  256 in total

1.  Magnetic enhancement of cell retention, engraftment, and functional benefit after intracoronary delivery of cardiac-derived stem cells in a rat model of ischemia/reperfusion.

Authors:  Ke Cheng; Konstantinos Malliaras; Tao-Sheng Li; Baiming Sun; Christiane Houde; Giselle Galang; Jeremy Smith; Noriko Matsushita; Eduardo Marbán
Journal:  Cell Transplant       Date:  2012-03-08       Impact factor: 4.064

Review 2.  Cardiomyocyte transplantation into the failing heart-new therapeutic approach for heart failure?

Authors:  Thorsten Reffelmann; Jonathan Leor; Jochen Müller-Ehmsen; Larry Kedes; Robert A Kloner
Journal:  Heart Fail Rev       Date:  2003-07       Impact factor: 4.214

3.  Endothelial cells promote cardiac myocyte survival and spatial reorganization: implications for cardiac regeneration.

Authors:  Daria A Narmoneva; Rada Vukmirovic; Michael E Davis; Roger D Kamm; Richard T Lee
Journal:  Circulation       Date:  2004-08-09       Impact factor: 29.690

Review 4.  Molecular imaging of cardiovascular gene products.

Authors:  Joseph C Wu; Jeffrey R Tseng; Sanjiv S Gambhir
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

5.  Improving viability of stem cells during syringe needle flow through the design of hydrogel cell carriers.

Authors:  Brian A Aguado; Widya Mulyasasmita; James Su; Kyle J Lampe; Sarah C Heilshorn
Journal:  Tissue Eng Part A       Date:  2011-12-20       Impact factor: 3.845

Review 6.  Using biomaterials to improve the efficacy of cell therapy following acute myocardial infarction.

Authors:  Jay H Traverse
Journal:  J Cardiovasc Transl Res       Date:  2011-11-17       Impact factor: 4.132

7.  Fabrication of functional three-dimensional tissues by stacking cell sheets in vitro.

Authors:  Yuji Haraguchi; Tatsuya Shimizu; Tadashi Sasagawa; Hidekazu Sekine; Katsuhisa Sakaguchi; Tetsutaro Kikuchi; Waki Sekine; Sachiko Sekiya; Masayuki Yamato; Mitsuo Umezu; Teruo Okano
Journal:  Nat Protoc       Date:  2012-04-05       Impact factor: 13.491

8.  Synthetic matrices to serve as niches for muscle cell transplantation.

Authors:  Sarah Fernandes; Shannon Kuklok; Joe McGonigle; Hans Reinecke; Charles E Murry
Journal:  Cells Tissues Organs       Date:  2011-10-14       Impact factor: 2.481

9.  Proangiogenic scaffolds as functional templates for cardiac tissue engineering.

Authors:  Lauran R Madden; Derek J Mortisen; Eric M Sussman; Sarah K Dupras; James A Fugate; Janet L Cuy; Kip D Hauch; Michael A Laflamme; Charles E Murry; Buddy D Ratner
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-09       Impact factor: 11.205

10.  Complex temporal regulation of capillary morphogenesis by fibroblasts.

Authors:  Jennifer R Hurley; Swathi Balaji; Daria A Narmoneva
Journal:  Am J Physiol Cell Physiol       Date:  2010-05-26       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.